Gen1E
Accelerating precision therapies for inflammatory and rare diseases
- Website
- gen1elifesci.com
About
GEn1E Lifesciences develops precision therapies for patients with inflammatory and rare diseases. Its discovery approach identifies new binding pockets that can target specific functions through allosteric binding, while its compounds use selective dual-signal modulation to treat inflammation. The company combines curated public and proprietary data with machine-learning models spanning drug discovery through clinical trials to accelerate development of its medicines.
Summary
Gen1E is a Biotech company.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/gen1e"><img src="https://indexed.vc/api/badge/company/gen1e" alt="Gen1E on Indexed.vc" width="260" height="76" /></a>